Purpose Fibrates are used to manage mixed dyslipidemia. However, these drugs have the
potential risk of inducing rhabdomyolysis. This paper gives an overview of the literature on …

Cardiovascular disease (CVD) represents the leading cause of mortality worldwide. Lifestyle
modifications, along with low-density lipoprotein cholesterol (LDL-C) reduction, remain the …

Probiotics have been reported to play an important role in the prevention of metabolic
disorders. We recently identified a novel probiotic strain Lactobacillus plantarum (L …

Objective: To evaluate the quality of available evidence of drug class combinations and their
association with the development of acute kidney injury (AKI). Data Sources: A search of …

We recently identified a novel probiotic strain Lactobacillus plantarum P-8 (L. plantarum P-
8), which has been characterized in detail with regard to its probiotic potential. In the present …

Methods This study examined the effects of switching treatment from fenofibrate to
pemafibrate in 16 aPBC patients. The biological parameters of these patients were …

In the treatment process of hypertriglyceridemia and diabetic nephropathy in type 2
diabetes, fenofibrate (FEN) is a well-known medication. FEN is from fibrate class drugs that …

Fibrates are a class of lipid-lowering medications primarily used as second-line agents
behind statins. The adverse-effect profile of fibrates has been marked by a puzzling yet …

FRANCO, D. et al. Interacciones medicamentosas de agentes hipolipemiantes:
aproximación para establecer y valorar su relevancia clínica: revisión estructurada. Farm …

Preapproval clinical trials examining the safety and efficacy of rosuvastatin demonstrated an
increased incidence of proteinuria, hematuria, rhabdomyolysis, and other acute kidney …